CASTRATE RESISTANT PROSTATE CANCER
Clinical trials for CASTRATE RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATE RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATE RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Cancer's weak spot in advanced tumors
Disease control Recruiting nowThis study is testing a new oral drug called ETX-19477 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can help control the cancer. Researchers are especially interested in enroll…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: 858 Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Two-Pronged attack tested for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing a new combination treatment for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies. It combines a targeted radiation drug that seeks out and destroys prostate cancer cells with an immunotherapy drug de…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug tested for Tough-to-Treat cancers
Disease control Recruiting nowThis is an early-stage study to check the safety and initial activity of an experimental drug called DR-0202. It is for adults with advanced cancers that have spread, returned, or stopped responding to at least two prior treatments. The main goal is to find a safe dose and see ho…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC